Scarlet exists to pull medical technology from the future to solve human health. Founded in 2021 by James Dewar and Jamie Cox, it is the world's only certification body specialised in AI-driven medical devices. Scarlet's assessment process is built for the AI world. That means manufacturers can certify devices, release vital updates, and expand product suites without unnecessary delays - ensuring life-changing technology gets to the people who need it.
Scarlet: Venture Capital Funding History
Scarlet
Scarlet
- Health
- London, United Kingdom
- £40m
- scarlet.cc
- Update Information
More venture news
- 14 Oct 2026

StrideStride raises a £4.6m seed round led by Arāya Ventures to offer diagnostics-driven preventative health memberships
SeedHealth - 13 Oct 2026

Log my CareLog my Care secures £2m in venture debt from Palatine Growth Credit to provide the care sector with digital management software
Venture debtHealth - 12 Oct 2026

ScarletScarlet unlocks a £40m Series B led by Headline for AI-native certification of medical software and devices
Series BHealth
